Filing Details

Accession Number:
0001127602-13-023097
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-18 17:49:10
Reporting Period:
2013-07-18
Filing Date:
2013-07-18
Accepted Time:
2013-07-18 17:49:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1448434 T Raymond Keane C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Svp General Counsel & Cco No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-07-18 8,000 $19.79 62,096 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold to satisfy witholding tax requirements related to the vesting of performance stock units previously reported. These shares were sold pursuant to a 10b5-1 trading plan adopted by the reporting person in December 2012.